Qiang Wang

Qiang Wang is a highly experienced scientist with a strong background in biomedical sciences, specializing in genomics and autoimmune disease research. Currently serving as a Senior Scientist at Tome Biosciences, Qiang Wang is involved in high-throughput screening and optimization for in vivo gene editing programs. Prior roles include Postdoctoral Research Fellow at both Boston Children's Hospital and Brigham and Women's Hospital, focusing on genetic variants associated with autoimmune diseases, and a Ph.D. candidate at Tufts University, where research centered on the role of Calpain in parasitic immune evasion. Qiang Wang also has experience in pharmaceuticals, having promoted Lipitor at Pfizer, and in the sports management sector as a management trainee at Evergrande Real Estate Group. Educational credentials include a Ph.D. from Tufts University in Biomedical Sciences and a BVM in Veterinary Medicine from Jilin University.